Fresh2 Group Limited (FRES)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Haohan Xu | Chairman of the Board & CEO | -- | -- | 1995 |
Ms. Xiaoyu Li | Director & CFO | -- | -- | 1989 |
Mr. Weidong Dai | China President | -- | -- | 1961 |
Dr. Sunil Pandit | U.S. Chief Executive Officer | -- | -- | -- |
Mr. Yidong Hu | Chief Strategy Officer | -- | -- | -- |
Fresh2 Group Limited
- Sector:?
- Healthcare
- Industry:? Biotechnology
- Full Time Employees:?
- 75
Description
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.
Corporate Governance
Upcoming Events
November 5, 2024 at 12:30 AM UTC - November 20, 2024 at 12:30 AM UTC
Fresh2 Group Limited Earnings Date